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Abstract The 11th Transgenic Technology meeting
was held in Guangzhou, China on 25th–27th February
2013. Over 300 scientists and students from round the
world gathered to hear the latest developments in the
technologies underpinning the creation of transgenic
and knockout animals and their application to biolog-
ical sciences in areas such as the modeling human
diseases and biotechnology. As well as informative
presentations from leading researchers in the field, an
excellent selection of short talks selected from
abstracts and posters, attendees were also treated to
an inspiring talk from Allan Bradley who was awarded
the 9th International Society of Transgenic Technol-
ogies Prize for outstanding contributions to the field of
transgenic technologies.
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Shortly after the 2013 Spring Festival welcoming in the
Year of the Snake, the 11th Transgenic Technology
meeting took place in Guangzhou, China. It is the first
time since the meeting began is Stockholm, Sweden in
1999 that it has visited Asia. We were very warmly
welcomed by our Chinese colleagues, who organised
the meeting on behalf of the International Society
of Transgenic Technologies (ISTT; www.
transtechsociety.org). Over 340 participants repre-
senting 29 countries gathered in the Baiyun Interna-
tional Convention Center, located in the shadow of
White Cloud Mountain in the North of Guangzhou.
The meeting provided a well judged program
combining innovative advances in the field as we as
practical applications of the technology and providing
a rewarding experience for delegates with differing
backgrounds. Over 3 days, the sessions covered a
wide variety of subjects such as welfare; cryopreser-
vation; epigenetics; functional genomics; embryonic
stem (ES) cells and targeted nucleases. In addition,
there was the now traditional round table discussion on
‘Aspects of Running a Transgenic Facility’. A couple
of highlights among many were the award of the 9th
ISTT prize to Allan Bradley (Wellcome Trust Sanger
Institute, Hinxton, UK) and the 2nd ISTT Young
Investigator Award to Toru Takeo (Division of
Reproductive Engineering, Center for Animal
Resources and Development-CARD, Kumamoto Uni-
versity, Japan). In addition a number of presentations
touched on the growing impact of the innovative
targeted nucleases in the generation of transgenics,
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especially in large animals. Another theme running
throughout the meeting was enormous progress and
investment made by our Chinese colleagues in the
areas of animal transgenesis and functional genomics.
Following the meeting there was a hands on
practical work workshop held at the Sun Yat-sen
University, Guangzhou. The workshop covered a
range of fundamental techniques underlying the
generation of transgenic mouse lines organised by
Wenhao Xu (University of Virginia, Charlottesville,
VA, USA; Chair), Ming Zhao (Southern Medical
University, Guangzhou, China), Jing An (Cancer
Institute, Southern Medical University, Guangzhou,
China) and Liangping Li (Sun Yat-sen University,
Guangzhou, China).
After the welcome address from Ming Zhao
(Southern Medical University, Guangzhou, PR China;
Chair of the TT2013 meeting) and Lluis Montoliu
(National Center of Biotechnology, CSIC, Madrid,
Spain; ISTT President), the meeting started appropri-
ately enough by a former ISTT prize winner, Qi Zhou
(The State Key Laboratory of Reproductive Biology,
Institute of Zoology, Chinese Academy of Sciences,
Beijing, PR China), the recipient of the 3rd ISTT prize,
who detailed his impressive achievements since
winning the prize. These included the generation of
stem cell derived mice and the generation of mice
from haploid ES cells. Jinsong Li (Institute of
Biochemistry and Cell Biology, Chinese Academy
of Sciences, Shanghai, PR China) then outlined the use
of haploid ES cells to produce semi-cloned mice. This
significant achievement represents a novel method of
generating mouse lines by using a stem cell to fertilise
an injected oocyte. In the final talk of the first session
Naomi Nagata (Center for Animal Resources and
Development, Kumamoto University, Japan) pre-
sented an overview of the remarkable progress made
in the field of sperm cryopreservation and in vitro
fertilization (IVF), a field in which his lab has been at
the forefront throughout.
The second session focused on high throughput
gene targeting and functional genomics initiatives.
Xiang Gao (Model Animal Research Center of
Nanjing University, Nanjing, PR China) outlining
the impressive progress made in his institution in the
generation and phenotyping of genetically altered
mouse lines, heralding ‘a new era for mutagenesis in
China.’ Michael Dobbie (Australian Phenomics Facil-
ity, The Australian National University, Canberra,
Australia) gave an overview of the Australian Phe-
nomics Network the creation and characterisation. He
also outlined their forward thinking approach com-
bining N-ethyl-N-nitrosourea (ENU) mutagenesis and
next-generation exome sequencing to rapidly identify
and exploit ENU alleles of genes of interest. Kent
Lloyd (University of California, Davis, USA) gave an
overview of the data generated and collated from users
of the Knockout Mouse Project (KOMP). Differences
in the efficiencies of a variety of different ES cell lines
in chimera generation and germline transmission rates
were discussed. In addition the advantages of culturing
embryonic stem cells in medium containing Map2k1
and Gsk3b inhibitors (2i) were outlined.
Following lunch the first session of the afternoon,
focused on what proved to be a recurrent theme
throughout the meeting, the application of targeted
nucleases to the generation of transgenic animals.
Although zinc-finger nucleases (ZFNs) and especially
transcription activator-like effector nucleases (TA-
LENs) are a relatively newly developed technology
these tools are already making a significant impact in
improving the efficiency with which precise genetic
modifications can be generated in an enormous variety
of species. This session reflected that with three talks
all on different species; mice, zebrafish and pigs.
Dietmar Kappes (Fox Chase Cancer Center, Philadel-
phia, PA, USA) firstly illustrated the approach using
ZFNs in mice. Using ZFNs his group were able to
make numerous precise modifications to the promoter
of the Zbtb7b gene, a transcription factor critical for
the development of helper T cells. Bo Zhang (College
of Life Sciences, Peking University, Beijing, PR
China) then discussed the relative ease with which
TALENs can be designed and generated. She then
went on to illustrate their use in a variety of
applications in genome modification in zebrafish. This
included heritable gene targeting and the generation of
large deletions in the zebrafish genome. Liangxue Lai
(Guangzhou Institutes of Biomedicine and Health,
Chinese Academy of Sciences, Guangzhou, PR China)
then illustrated the use of ZFNs for generation of a
PPAR-g gene knockout in pigs. After modification of
the gene in fibroblasts, heterozygous animals were
generated by nuclear transfer. One note of caution
using this technology was that the group also found
mutations in 2 of 37 predicted off-target sites.
Next up was the popular round table discussion on
‘How to run a transgenic unit.’ After an introduction
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from the session chair Jan Parker-Thornburg (MD
Anderson Cancer Center, Houston, TX, USA), the first
talk was given by Xin-an Pu (The Ohio State Univ.,
Comprehensive Cancer Center, Columbus, OH, USA)
on trouble shooting, what can go wrong with a variety
of the techniques underpinning the generation of
transgenic mice, such as superovulation, rederivation
and DNA preparation. Xin-an then described what to
do when things go wrong and how to avoid some
common pitfalls. Benoıˆt Kanzler (Max-Planck Inst.
for Immunobiology and Epigenetics, Freiburg, Ger-
many) gave an excellent presentation on the very
challenging subject of how to develop cutting edge
technologies while maintaining an excellent basic
service. Central to Benoıˆt’s ideas, were creating the
right environment to foster new ideas and having the
organization and desire to push new ideas thorough to
completion. These are key aspects to help facilitate the
development of new technologies. Thomas Kolbe
(Biomodels Austria & Inst. For Biotech. in Animal
Production, Tulln, Austria) then outlined the factors
that you require to take into account when running a
transgenic unit as a business.
After the conclusion of the stimulating discussion,
Lluı´s Montoliu (National Center of Biotechnology,
CSIC, Madrid, Spain; ISTT President) and Yacine
Cherifi (genOway, Lyon, France) presented the 9th
ISTT Prize for outstanding contributions to transgenic
technologies to Allan Bradley (Wellcome Trust San-
ger Institute, Hinxton, UK). During the subsequent
Prize Lecture, Allan gave a personal account of his
role in the development and application of embryonic
stem cells. After Martin Evans had pointed him in the
direction of the lab and suggested he should ‘do
something useful,’ Allan described how he set about
doing exactly that! From ‘not even knowing what a
stem cell was’ through developing his own electropo-
rator which required a key and pair of welly boots,
Allan described his role at the forefront of develop-
ment of technology that literally revolutionized func-
tional genomics in the mouse. This involved the
development of numerous techniques and reagents
which are so widely used today that they can be called
standard practice, to his role in developing and
overseeing the mouse genome sequencing and char-
acterisation and the development of high throughput
gene targeting technology. Together these have facil-
itated the extraordinary achievement of targeting the
vast majority of genes in mouse, a embryonic stem
cells, a resource which will allow the study of gene
function in a way that was virtually unthinkable, even
a few years ago.
The first session of the second day was dedicated
mainly to assisted reproduction strategies in mice.
Before concentrating on that topic the first speaker,
Depei Liu (Chinese Academy of Medical Science and
Peking Union Medical College, Beijing, PR China)
gave an insight into the use of mouse models in
cardiovascular research. In particular the atheropro-
tective role of Sirt1 was discussed, and its mechanism
of action through repression of Shc1, Ccnd1 and
Mmp9. Fernanado Benavides (MD Anderson CC,
Smithville, TX, USA) gave an illustration of the
highly important subject of genetic background and
how that can influence the outcome of transgenic
experiments. In particular a number of commonly used
inbred mouse strains carry specific mutation which
can influence the phenotype of interest.
Shannon Byers (The Jackson Laboratory, Bar
Harbor, ME, USA) then discussed the advantages of
being able to use cryopreserved embryos for blastocyst
injection, as well as the development of the ‘perfect
host’ strain. These animals are rendered sterile by
expression of DTA in the germ cells of the testis,
allowing the ES cells space to colonize. Consequently
any offspring they produce must be ES cell derived.
Francina Langa (Institut Pasteur, Paris, France) pre-
sented an assessment of the efficiency of using frozen
embryos for blastocyst injection. Although these do
work, the efficiency of live birth and chimeras is
significantly reduced. Consequently it is necessary to
weigh up the convenience of using frozen embryos
against the reduction of efficiency in the setting of
your particular experiment. Gonzalo Moreno (Institu-
to de Neurociencias de Alicante, CSIC/UMH, Ali-
cante, Spain) then outlined methodology he had
developed allowing the serial surgical collection of
sperm samples from mice, without significantly
affecting their fertility.
The sixth session at the meeting was dedicated to
discussion of ethics and welfare. Malcolm France
(University of Sydney, Australia) started off the
discussion relating the story of Frances Power Cobbe
and the lessons we can learn from the history of the
animal rights movement. Catheryn O’Brien (The
Walter and Eliza Hall Institute, Melbourne, Australia)
then talked about health monitoring programs in
transgenic facilities, and the need to balance the costs
Transgenic Res (2013) 22:667–671 669
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of a monitoring program with the efficiency of
pathogen detection. Catheryn also discussed strategies
to avoid spread to disease in a colony and the methods
that would facilitate detection. James Bussell (Well-
come Trust Sanger Institute, Hinxton, UK) then gave
an impressive illustration of how the factors affecting
efficiency of the procedures involved in the production
and phenotyping of transgenic colonies can have a
dramatic effect on the numbers required within a
colony. Careful monitoring of performance indicators
can be used to optimize productivity, which conse-
quently has a beneficial effect not only on the quality
of the science but also the welfare of the animals.
Two short talks selected from the abstract followed.
Firstly, Weibke Garrels (Institute of Farm Animal
Genetics, Friedrich-Loeffler-Institut, Mariensee, Ger-
many) described the use of transposons to efficiently
introduce defined genetic alterations into the pig
genome, in the process identifying permissive loci
for gene expression and developing antibiotic-free
recombination-mediated cassette exchange and the
application of these techniques to the analysis of skin
transplantation. Guochun Gong (Regeneron Pharma-
ceuticals, Inc., Tarrytown, NY, USA) then described
the development and characterization of a self deleting
antibiotic selection cassette combining a sperm spe-
cifically expressed Cre recombinase along with the
antibiotic selectable marker.
After a break for lunch and an opportunity to view
some of the excellent posters the afternoon’s session
was dedicated to the effects of epigenetics of mamma-
lian development and the consequences for the gener-
ation of transgenics. Alfonso Gutie´rrez-Ada´n
(Department on Animal Reproduction, INIA; Madrid,
Spain) gave the first talk of the afternoon about the
effects of in vitro culture on mammalian embryos, and
the consequential lasting effects on phenotypes in the
adult. Alfonso described how culture in suboptimal
conditions may lead to changes in body weight organ
size and fertility of adult mice. Takashi Kohda (Depart-
ment of Epigenetics, Medical Research Institute, Tokyo
Medical and Dental University, Japan) then described
the gene expression changes induced by intracytoplas-
mic sperm injection (ICSI) which produce marked
changes in neonatal mice, but which diminish as the
mice become adults. Takashi also showed that there is
an overlap between gene expression changes produced
by ICSI and somatic cell nuclear transfer suggesting a
common underlying mechanism. Guo-Liang Xu
(Institute of Biochemistry and Cell Biology, Chi-
nese Academy of Sciences, Shanghai, PR China)
described his fascinating work on the mechanisms
underlying methylation of the paternal genome in
zygotes shortly after fertilization. Guo-Liang described
the roles of Tet dioxygenases in the modification of
5-methylcytosine and the subsequent base excision and
repair by Tdg. This represents a novel pathway for active
demethylation of the genome.
Following a short break there followed a General
Assembly of the ISTT and then the meeting banquet,
where everybody was treated to some fabulous local
cuisine and then danced the night away until the wee
small hours.
The third day of the meeting began with a session
dedicated to generating transgenics in large animals.
Ning Li (State Key Laboratories for Agrobiotechnol-
ogy, China Agricultural University, Beijing, PR
China) started the session talking about genetically
engineering of large animals in China and the
spectacular progress they have made in recent years.
This included numerous examples of transgenic and
knockout pigs and cattle. Several different strains of
transgenic cattle are now going through biosafety
analysis in China with a view to bring these to the
market in the next few years. Scott Fahrenkrug
(Recombinetics, Minneapolis, MN, USA) outlined
the remarkable progress in generating transgenic and
knockout pigs and cattle using TALENs. In addition to
producing single knockouts by introducing these
targeted nucleases into pig fibroblasts, it is also
possible to combine multiple TALENs and generate
knockouts at two separate alleles simultaneously.
Scott also explained that one important and significant
advantage of using TALENs is the ability to introduce
naturally existing alleles with no requirement to
introduce a selectable marker without any footprint.
Shoukhrat Mitalipov (Oregon National Primate Res.
Center, OHSU, Beaverton, OR, USA) then described
the difficulties in generating and validating primate ES
cells and the progress made toward a treatment for
mitochondrial diseases using a spindle transfer proto-
col developed in his lab.
Following the session on non-rodent transgenesis, the
ninth session of the meeting was devoted to resources
available for analysis of transgenic rodents. Yann
Herault (Institut Clinique de la Souris, ICS and IGBMC,
Illkirch/Strasbourg, France) started off giving an
impressive overview of Cre mouse line resources
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available and where to get access to these. As well as an
introduction to the technology Yann described the
various repositories available, and the efforts to generate
a CreERT2 resource. Takashi Kuramoto (Institute of
Laboratory Animals, Kyoto University, Kyoto, Japan)
gave the next presentation in the session describing the
Japanese National BioResource Project for the Rat. This
project includes the bio-banking of a variety of rat
strains as well as the Rat Phenome Project. One example
Takashi described was the development of a colon
cancer model, using a point mutant allele of Apc, with
one significant advantage of a rat model being the
possibility to use endoscopic observation and even the
ability to biopsy the tumours in situ.
The penultimate session of the meeting was devoted
to applications of ES cell technology. Zhu-Gang Wang
(Shanghai Research Center for Model Organisms,
Shanghai, PR China) described the mouse mutagenesis
program at the Shanghai Research Center. Zhu-Gang
then went on to demonstrate that by generating and
analysing knockouts of genes with unknown function
they were able to come full circle and show that some of
these, such as Prss37, a gene the group discovered to be
involved in fertility, may play an important role
underlying human disease. Masaru Okabe (Genome
Information Research Center Research, Institute for
Microbial Diseases, Osaka University, Osaka, Japan)
demonstrated the progress that his group had made
toward differentiation of stem cells into organs. Using
rat/mouse interspecies chimeras the group had differ-
entiated rat ES cells into a thymus in a mouse host and
then successfully transplanted it back into rats restoring
some function. Pentao Liu (Wellcome Trust Sanger
Institute, Hinxton, UK) described the important work
his group has done in defining additional genes impor-
tant for improving the efficiency of generating induced
pluripotential stem cells (iPSCs). In addition Pentao
described the use of TALE transcription factor directed
to activate the Oct4 locus could be used to reprogram
mouse embryonic fibroblasts into iPSCs. Furthermore
Pentao described that using this technology on human
cells results in iPSCs which are mouse like mouse ES
cells than iPSCs generated by conventional technology.
The final session of the meeting began with the
presentation of the 2nd ISTT young investigator
award. Ailan Lu (inGenious Targeting Laboratory,
Inc., Ronkonkoma, New York, USA) and Lluı´s
Montoliu (National Center of Biotechnology, CSIC,
Madrid, Spain; ISTT President) introduced the
recipient, Toru Takeo (Division of Reproductive
Engineering, Center for Animal Resources and Devel-
opment-CARD, Kumamoto University, Japan) who
received the award for his work in improving mouse
sperm cryopreservation and IVF. Toru then presented
his award lecture demonstrating the spectacular
improvements that he had developed in those areas.
At the conclusion of his excellent presentation prizes
for the best posters presented at the meeting were
awarded to: Da-Wei Yu (State Key Laboratories for
Agrobiotechnology, China Agricultural University,
Beijing, PR China) for his poster ‘Expression of
Intracellular interferon-a in cloned transgenic cattle’;
Ben Davies (Wellcome Trust Centre for Human
Genetics, Oxford, UK) for his poster ‘High efficiency
sequence specific mutagenesis on CD1, C57Bl6/J and
C3H genetic backgrounds by microinjection of TAL-
Effector nucleases (TALENs) mRNA’ and Wojtek
Auerbach (Regeneron Pharmaceuticals, Inc., Tarry-
town, NY, USA) for his poster ‘Generation of fully
fertile F0 XY female mice from XY ES cells by
manipulation of ES cell growth conditions.’
All in all the 11th Transgenic Technology Meeting
proved to be a real success and will be a hard act to
follow. A very well done to Ming Zhao and the rest of
his organising team who were excellent hosts, making
everyone feel extremely welcome. The meeting pro-
vided the chance to see some excellent presentations at
the forefront of the latest innovations on transgenic
technologies. Moreover, in addition to excellent
science there were plenty of opportunities to catch
up with old friends and also to make new ones. This is
what these meetings are all about. The next opportu-
nity for such a get together will again be in 18 months
time in October 2014. For its next meeting the ISTT
has chosen to come back to Europe and for the first
time to the historic city of Edinburgh, Scotland UK.
The city of Edinburgh has a rich scientific history from
Charles Darwin and James Maxwell to Peter Higgs
and Ian Wilmut; the atmospheric cobbled streets of the
Old Town will provide a spectacular backdrop to the
presentation of the newest innovations in transgenics.
We are both very much looking forward to welcoming
you all to Edinburgh next year!
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use,
distribution, and reproduction in any medium, provided the
original author(s) and the source are credited.
Transgenic Res (2013) 22:667–671 671
123
